On July 20, 2009, Shareholders of Wyeth (“WYE”) voted concerning the proposed merger with Pfizer Inc. (“PFE”). The merger was approved and subsequently consummated on October 15, 2009. As a result, each existing WYE Common Share will be converted into the right to receive .985 PFE Common Shares and $33.00 Cash. Cash will be paid in lieu of fractional PFE shares.
This action will be coordinated with the Options Clearing Corporation.
Register for regular updates here and manage your email preferences.